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INTRODUCTION
A woman's reproductive history is one of the principal determinants of her susceptibility to breast cancer. An early full-term pregnancy is protective and the length of time between menarche and the first full term-pregnancy appears to be critical for the initiation of breast cancer. This study is based upon the hypothesis that the protective effects of an early pregnancy and lactation result from estrogen (E) and progesterone (P)-induced differentiation and the resultant loss of cells susceptible to carcinogenesis. These effects of E and P are mediated by the induction of specific "local mediators", i. e. growth factors that act via autocrine and paracrine mechanisms to influence terminal duct (TD) and end bud (TEB) growth and differentiation. These rapidly proliferating cells are the most susceptible to neoplastic transformation. No molecular markers are available to identify and follow the fate of these susceptible cells, yet this information is required to develop effective diagnostic tools and preventive therapies for breast cancer. Thus, the initial objective of this study is to identify molecular markers for TEB and TD cells in order to follow their fate during mammary development and carcinogenesis. To do so, genes expressed in the TEBs of the nulliparous rat mammary gland will be isolated, cloned and characterized. These genes will then serve as molecular markers in TEB cell fate studies. Candidates for TEB molecular markers may include cell cycle factors, proteins which interact with the extracellular matrix, cytoskeletal elements and growth factor receptors. In addition, we proposed to define the topology and compare stages of the cell cycle of susceptible and refractory cells, and to identify local mediators of E-and P-treatment in the end buds and surrounding stroma, and characterize the changes in their expression patterns.
The following specific tasks were proposed for the third twelve month period of this proposal.
Task 2c. Northemn analysis to follow the fate of these unique gene transcripts during mammary development and carcinogenesis.
Task 3. Definition of the topology and cell cycle analysis of susceptible and refractory cells.
Task 4. Identification of local mediators of E-and P-treatment in the end buds and surrounding stroma and characterization of the changes in their expression patterns. Specifically, the characterization of changes in the levels of expression of known growth factor family members as a function of E-and P-treatment by quantitative RT-PCR.
BODY

Materials and Methods
Animals
Wistar Furth rats with an inbred genetic background were obtained from Harlan Sprague Dawley, Inc. USA. Mouse tumors and cell lines were provided by Dr. Daniel Medina, Baylor College of Medicine. All animals were maintained and sacrificed according to IACUC approved guidelines. 
Cell lines
Probes and antibodies
A full length pl90-B cDNA expression construct was a generous gift of Dr. Peter Burbelo, Laboratory of Developmental Biology, National Institute of Dental Research. The full length adrenomedullin cDNA was the kind gift of Dr. Junichiro Sakata, First Department of Internal Medicine, Miyazaki, Japan. Rabbit polyclonal antibodies for p190-B were raised against two synthetic peptides and were affinity purified. The secondary antibody and peroxidase conjugated antibodies were purchased from SantaCruz Biotechnology.
Cell culture and transfection
In order to obtain cells expressing p190-B, 5gtg of plasmid DNA containing a neomycin resistance gene and 5ug of stuffer plasmid DNA were co-transfected into COS 1 cells using the lipofectamine reagent (Boehringer Mannheim). After 5-8 hrs the transfection medium was supplemented with medium containing 20% fetal bovine serum (FBS). The media was replaced after 18 hrs with fresh media containing 10% FBS. Cells were harvested after 24hrs and stored at -80'C until analyzed.
Preparation and analysis of RNA
The fourth abdominal mammary glands from virgin, pregnant and lactating rats were dissected under anaesthesia using standard surgical procedures. Tissue was snap frozen in liquid nitrogen and stored at -80'C. Total cellular RNA was prepared using 4M guanidium isothiocynate and CsCl buoyant density centrifugation (Maniatis, 1988) . RNA was fractionated on a 1.2% formaldehyde agarose gel and transferred to Hybond N+ (Amersham) membrane with 1OX SSC. Hybridization was performed in Hybaid oven at 65'C using procedures recommended by Amersham.
Preparation of protein extracts and Western blot analysis
Protein extracts were prepared by lysing the cells in RIPA buffer (Upstate Biotechnology), followed by precleaning and protein concentration determination (Bio-Rad 96 well plate method). For Western blot analysis, 50-100 jig of protein extract from transfected cells or tissue was subjected to electrophoresis through a 6% PAGE-SDS gel. Proteins were electroblotted to PVDF membranes. Filters were blocked with 3%NFDM in TBST and incubated for 1 hr with affinity purified polyclonal antibody for p190-B diluted (1:1000) in blocking buffer. This was followed by incubating the blot with secondary antibody (goat anti rabbit) diluted (1:2000) in blocking buffer. Detection was performed with the enhanced chemiluminescence detection system (Pierce Chemicals).
Cell kinetics
Mammary glands representing additional positive controls were excised from 104 day old virgin rats. BrdU (50 jig/kg) was injected ip at 104 days of age and animals were sacrificed at 4 hr intervals during the following 28 hr period. An additional 30 rats were subjected to double exposure to MNU at 97 and 104 days and then divided into two subgroups. Subgroup 1 received BrdU injections at 104 days and their mammary glands collected every 4 hrs for 28 hrs. Subgroup 2 received BrdU injections at 109 days and their mammary glands collected every 4 hrs for 28 hrs.
All mammary glands were frozen at -80'C, sectioned on a cryomicrotome at 50 jim thickness, and collected on washed glass slides. The sections were permeabilized by treatment with 0.5% Triton-X 100 in PBS for 4 min at RT. The tissue slices were then fixed in 4% formaldehyde in PBS for 15 min at RT. After treatment with 2.5N HCl at room temperature for 40 min to denature the DNA, the slices were stained with mouse-anti-BrdU antibodies (Boehringer Mannheim) and rabbit anti-keratin 14 (1:500) at 37'C for 3 hrs.
After washing, the samples were incubated with a mixture of three secondary antibodies (FITC-conjugated anti-mouse; a goat-anti-rabbit FITC conjugated anti-K14; and an RITC conjugated goat anti-rabbit antibody). The latter combination of antibodies at a 1:1 mixture produces yellow color in myoepithelial cells. The tissue slices were then stained with propidium iodide (1 gtg/ml). This combination of treatments produces a tri-colored histological preparation that enables us to identify and analyze the proliferative compartment of the mammary gland (Sphase cells are green, all other nuclei are red and the myoepithelial cells are stained yellow). The slides were examined by a laser scanning confocal microscope (Molecular Dynamics), operating at an optical section step size of 5 gtm thickness. The images are recorded as TIFF or JPG files for cell cycle scoring.
Combination BrdU/Histone H3 staining for mitotic cells
In order to determine complete cell parameters, it is necessary to score the % of BrdUpositive mitotic cells following an earlier pulse with BrdU. Until recently, this was not possible using confocal microscopy. This limitation was overcome by staining cryosections of rat mammary glands with a new mitosis-specific antibody made against the phosphorylated form of the amino terminus of histone H3 (anti-H3) obtained from Dr. C. David Allis (University of Rochester). Following the anti-BrdU step described above, the slides were washed and exposed to the anti-H3 (1:1000 in PBS plus 1% BSA for 3 hrs). After washing, the samples were treated with Texas Red-labeled goat anti-rabbit IgG. Using this scheme, BrdU-labeled nuclei are green, mitotic cells are red, and BrdU-labeled mitotic cells are yellow.
Centrosome amplification as a marker for genome instability
Centrosome replication is a useful marker for identifying cells in the cell cycle and for detecting early stages of genome instability (Fukasawa et al., 1996) . We adapted this technique for analyzing the cells of the rat mammary gland as well as MNU-induced mammary tumor cells. Cryosections of mammary glands and tumors were obtained as described earlier. In addition to the other antibodies, the sections were incubated with SPJ anti-centrosome serum provided by Dr. Ron Balczon (University of South Alabama) at a dilution of 1:500 for 3 hrs at 37°C, followed by exposure to FITC-goat-anti-human IgG for 3 hrs at 37°C. Scoring was accomplished by counting the number of stained nuclei and the corresponding number of centrosomes in sections of both mammary gland and tumor.
Isolation and analysis of nuclear matrix proteins A full set of 2-D patterns of nuclear matrix proteins from TEB, TEB-associated stroma, AB and AB-associated stroma was obtained by the following procedure. The mammary glands from 8-10 rats (45 day old) were excised after injections of 0.5% Trypan Blue into the nipple to reveal the mammary tree. Each gland was dissected into two anatomical regions consisting of the midgland, rich in alveolar bud (ABs) and the terminal region, rich in terminal end buds (TEBs) as shown in Figure? . After treatment with collagenase (2 mg/ml) at 37'C for 1.5 hrs, the tissues were washed in DMEM and centrifuged at 500Xg multiple times in order to separate stroma from glands. The process of digestion and separation was monitored by microscopy assays, assuring that clean preparations of ABs, TEBs and stroma were obtained. This procedure produced four fractions: (1) TEBs, (2) TEB-associated stroma, (3) ABs, and (4) AB-associated stroma. Four fractions were placed into CSK buffer and homogenized in 0.5% Triton X-100 to release lipids and soluble proteins. The samples were then centrifuged and incubated with 50-200 Rg/ml RNasefree DNase I in CSK buffer at 32'C for 45 min, followed by extraction in 0.25 M ammonium sulfate in CSK buffer. After centrifugation, the pellet was incubated in 1.6 M NaCl for 5 min at room temperature. The pellet was then washed in CSK buffer and frozen at -80°C. The samples were then sent to Zaxis, a biotech company in Audson, Ohio, who processed and stained the 2-D gels according to the high resolution color-based silver staining procedure.
Results and Discussion
Task 2c. Northern analysis to follow the fate of these unique gene transcripts during mammary development and carcinogenesis.
DD-PCR was used to identify candidate genes that may play a role in mammary gland development and neoplasia. As described previously, a total of 14 clones were identified. The RNA expression levels of EDD-C3, C6, C11, C14, C15, C18, G5, G6 and G7 were analyzed by RT-PCR in an attempt to identify clones which are expressed predominantly in the TEB RNA. Four clones; EDD-G5, G6, G7 and C18 were more highly expressed in the TEB RNA. Interestingly, EDD-G6, G7 and C 18 are clones which were originally isolated from a DD-PCR experiment in which two separate RNA pools were used for duplicate PCR runs. These results are promising, however there were problems with variability of clone expression between the individual RNA preparations studied. This is most likely due to variation in the amount of ductal and stromal contamination in the original pooled dissection fractions used for RNA isolation.
Because RT-PCR analyses of pooled fractions does not permit a conclusive identification of the cell types expressing specific RNA transcripts, experiments are in progress to localize the expression of clones EDD-C2, C12, G5, G6, G7 and C18 by in situ hybridization in the virgin rat mammary gland. The major problem we have encountered is the ability to perform in situ hybridization for scarce mRNA transcripts at sufficient resolution to localize transcripts at the cellular level. Initially, in situ RT-PCR (IS-PCR) of differential display clones was attempted to localize mRNA expression to specific cell types in the virgin gland. However, there was little success in the virgin mammary gland due to high background levels, possibly due to DNA and the rTth polymerase. We are currently optimizing more conventional methods of in situ hybridization using 3 S-UTP-labeled riboprobes.
While some of the clones identified by DD-PCR may be false positives or less interesting, e.g. cytochrome C oxidase, four clones (three of unknown identity) are preferentially expressed in the TEB fraction. One of these DD-PCR cDNAs, EDD-G5, which was originally identified as an Expressed Sequence Tag (EST), has recently been found to be related to a novel mammalian LDL family member termed LR1 1. Additionally, both adrenomedullin, a secreted peptide factor, and pl90-B, a new Rho GAP protein, initially appear to be expressed in the TEB and may play important roles in regulating TEB proliferation and apoptosis.
Of the 14 clones originally identified and sequenced, two clones 98-100% homologous with known genes, were selected for detailed analysis because of their potential importance in mammary gland development. For example, DD-PCR clone C-2 was found to be 98% homologous to pl90-B. Similarly DD-PCR clone C-12 was 100% homologous to adrenomedullin. Our immediate goal, therefore, was to investigate the role these genes may play in mammary gland development and neoplasia and to determine if they are developmentally regulated. However, when these DD-PCR clones that were only 241 and 108 bp in length were employed as probes for Northern blot analyses, the signal to noise ratio was not sufficient to detect specific transcripts in total RNA preparations. Although we were previously able to detect expression of these clones in the virgin mammary gland using RT-PCR this technique was not amenable to quantitative studies in the absence of appropriate internal standards. One solution to this problem was the generation of longer cDNA probes. Accordingly, we have prepared a cDNA library from RNA isolated from the mammary glands of 45-day old rats. This library will be screened to obtain full length cDNAs encoding the previously described three novel clones isolated by DD-PCR and their complete sequences determined and compared to known sequences in the database. We were fortunate, however, to obtain full-length clones encoding both p190-B and adrennomedulin from other investigators to use in Northern blot analysis.
p190-B is developmentally regulated
We have analysed the expression of p190-B in various adult rat tissues and in mammary glands of Wistar Furth rats at different developmental stages. RNA from p190-B transfected COS 1 cells was used as a positive control. As expected from earlier results (Burbelo et al., 1995) , p190-B was found to be expressed in several adult tissues including lung, liver, kidney, brain and heart. It is expressed at much lower levels in ovary and uterus (Fig. 1) . Interestingly, p190-B was not only expressed in mammary gland, but was also developmentally regulated. The highest expression was seen in virgin mammary glands of a 45 day old animal, the time at which TEB activity is maximal. The expression of p190-B mRNA was found to be slightly down regulated in the virgin mammary glands of a 120 day old animal. The mRNA level increased once again at mid-pregnancy, but was not detectable by day 18 of pregnancy. To confirm these observations, the experiment was repeated using two different concentrations of RNA ( Fig. 2A ) and expression quantitated using the Molecular Dynamics Phosphoimager (Fig. 2C) . The ethidium bromide stained agarose gel provided a control for RNA loading (Fig. 2B ), but the blot still needs to be reprobed with another epithelial marker gene, such as that encoding keratin-18 to normalize for changes in epithelial cell populations during development. Studies are in progress to determine if p190-B expression is influenced by E and P, and to compare levels of expression in the mammary glands of age-matched nulliparous and parous rats.
Based on our observation that p190-B was expressed at higher levels in the mammary glands at stages representing increased proliferation, i.e. 45-day virgin and early-mid-pregnancy, and was down regulated at late pregnancy, we have also performed a preliminary analysis of its expression in a limited number of established mouse mammary cell outgrowth lines with differing tumorigenicities. The expression of p190-B mRNA appears to be increased in the more highly tumorigenic cell lines and tumors (Fig. 3A & B) . The expression of pl90-B mRNA was more abundant in high grade tumors as compared to more differentiated cell types (TM 2L) (Fig. 3) . These preliminary studies will be extended to examine p190-B expression in a series of hormonedependent MNU-induced rat mammary gland carcinomas following castration and E and P readministration.
Detection of p190-B in mammary gland extracts
In order to detect p 190-B expression in the mammary gland extracts of Wistar Furth rats by Western blotting, we raised antisera against two different peptides from the carboxyterminus (a.a. regions 1018 -1033, peptide-1 and a.a 1130 -1145, peptide-2) of human p190-B. This region is absolutely conserved between rats and human. The antibodies were affinity purified and titrated by ELISA. Of the two antibodies, the rabbit polyclonal antibody against peptide-2 was of higher affinity. We have thus used only this antibody for our further studies. The specificity of the antibody was determined by assaying p l90-B expression in COS 1 cells transiently transfected with a p190-B expression vector. This provided the positive control necessary to characterize these affinity purified rabbit polyclonal antipeptide antibodies. The peptide -2 antibody recognizes the expected 190 kDa protein with an additional 66 kDa crossreactive protein (Fig. 4A ). The expression of the p190-B protein was also detected in nontransfected cells, although at a decreased level, possibly because COS 1 cells are derived from kidney cells of African green monkey, a tissue known to overexpress p190-B. The specificity of the antibody was demonstrated by competition by peptide-2 (Fig. 4B ), but not by peptide-1 (Fig. 4C) . We also detected p190-B expression in extracts of the mammary gland of a rat at day 6 of pregnancy, and of the kidney (data not shown). The protein is expressed in both tissues, although in much lower levels than the transfected COS 1 cells. This antibody will now be employed to study the expression and localization of p190-B during mammary gland development using both conventional immunohistochemistry as well as for confocal microscopic analysis on thick frozen sections as described below.
Expression of adrenomedullin mRNA in the mammary gland EDD-C12 is rat adrenomedullin, a secreted peptide factor that is expressed in a variety of tissues (lung, heart, kidney, brain and mammary gland) and a potent vasodilator. Polyclonal antiserum and peptide antigen to adrenomedullin have been obtained from Dr. Frank Cuttitta at the NIH. The rabbit polyclonal antiserum was generated against the most C-terminal 30 amino acids of the adrenomedullin active peptide (116-146 a.a.). This antiserum reacts with the 18 kDa proprotein, a 14 kDa intermediate form and the 6 kDa active peptide. The polyclonal antiserum has been used to determine the temporal and spatial expression of adrenomedullin in the mammary gland by immunohistochemistry. As reported previously in the year 2 progress report, immunohistochemistry was performed with fixed sections of rat mammary glands from various time points throughout mammary development. Adrenomedullin was localized to the cytoplasm of epithelial and stromal cells of the virgin gland. Staining was most prominent in TEB and ductal epithelium. However, staining was also detected in the alveolar buds, stroma, blood vessels and lymph node. This adrenomedullin staining could be competed with the adrenomedullin peptide but not with a nonspecific peptide. In the 12 day pregnant gland, adrenomedullin expression was pronounced throughout the cytoplasm of alveoli, ducts and stroma. Interestingly, in the 18 day pregnant gland adrenomedullin was localized to the nucleus and cytoplasm of alveoli and cells of the stroma. Nuclear staining was also observed in lactating (2 days) and involuting (3 days) tissue but to a lesser extent. The cytoplasmic staining of the epithelium and stroma also continued through lactation and involution. In all cases, adrenomedullin staining could be competed with the specific peptide.
Because adrenomedullin is a secreted growth factor that can act in both a paracrine and autocrine manner we wanted to complement these studies of immunolocalization to determine the levels of adrenomedullin mRNA in the mammary gland at different stages of development. Once again, we were fortunate to obtain a full length cDNA probe from Dr. J. Sakata. As reported previously, adrenomedullin mRNA was found to be universally expressed with kidney, heart and ovary showing the highest expression (Fig. 5 ). Moderate expression was seen in brain and virgin mammary gland, and uterus, lung and liver show low levels of expression The mRNA appears to be slightly down-regulated during lactation. In order to determine which cell types are synthesizing adrenomedullin mRNA during mammary gland development it will be necessary to complement these studies with in situ hybridization analysis. To accomplish this goal the fulllength cDNA will be cloned into a vector to generate both sense and antisense 3 5 S-riboprobes for in situ hybridization.
E and P regulation of local growth factors
The regulation of the Wnt and Fgf growth factor families by steroid hormones appears to play an important role in mammary tumorigenesis and breast cancer. We have studied steroid hormone regulation of Wnt gene expression in intact and progesterone-receptor knockout (PRKO) mice. Mouse mammary gland development has also been examined in PRKO mice using reciprocal transplantation experiments to investigate the effects of the stromal and epithelial PRs on ductal and lobuloalveolar development (Humphreys et al., 1997, copies appended). The absence of PR in transplanted donor epithelium, but not in recipient stroma, prevented normal lobuloalveolar development in response to estrogen and progesterone treatment. Conversely, the presence of PR in the transplanted donor epithelium, but not in the recipient stroma, revealed that PR in the stroma may be necessary for ductal development. Stimulation of ductal development by the progesterone receptor may, therefore, be mediated by a unknown secondary signaling molecule, possibly a growth factor. The continued stimulation of the stromal PR appears to be dependent on reciprocal signal(s) from the epithelium, and in the PRKO mouse this feedback loop is interrupted. Thus, the combination of gene knockout and reciprocal transplantation techologies has provided some new insights into the role of stromal-epithelial interactions and steroid hormones in mammary gland development. Wnt-2 gene expression is maximal in the mammary stroma of 4-6 week old mice and is repressed by estrogen, while Wnt-5b is expressed in lobuloalveolar cells and is dependent upon the presence of intact PR in the epithelium.
Task 3a. Definition of topology and cell cycle analysis of susceptible and refractory cells by confocal microscopy (continued from year 2).
As reported in the Progress Report for year 2, our experiments have continued to focus on determining the growth fraction (GF), labeling index and fraction of cells in S-phase in control 45 and 96 day old rats from thick frozen sections examined in 3-D by confocal microscopy. The control data-base has now been extended by analyzing cell kinetics in the mammary glands from 15 virgin rats injected with BrdU (50 ptg/kg) at 104 days, after which two animals were sacrificed every four hours for 24 hours. The results to date are consistent with published accounts of cell kinetics in older virgin rats. In another group, MNU was administered to virgin animals at days 97 and 104 days. Subsequently, these animals were divided into two groups: group one consisted of 15 animals that received BrdU immediately after the second exposure to MNU at 104 days, group two consisted of 15 animals that received BrdU injections five days following the last exposure to MNU. Two animals were sacrificed every 4 hrs following each of these treatments and the mammary glands were excised, frozen at -80'C and later fixed and cryosectioned for confocal microscopic analysis as described in the 02 year report. At the time of this report, cell cycle analysis by confocal microscopy is being conducted on tissues from the 30 animals in this experiment. The data is being collected and will be compared to the 45, 96 and 104 day old control animals.
Our efforts to completely analyze the cell cycle in rat mammary glands have been hampered by our inability to accurately determine the % of BrdU-labeled mitotic cells in thick cryosections. This step is essential for establishing the duration of M and G 2 phases. We have recently overcome this problem through the availability of a new antibody specific for the phosphorylated form of the amino terminus of histone H3 (serlO), a specific marker for condensed chromatin in mitotic cells (Hendzel et al, in press) as shown in Figure 6 . We have now added this probe to our standard protocol, making it possible to determine the complete cell cycle along with labeling index and growth fraction from thick frozen sections.
We have also adapted a new procedure for identifying mammary gland cells that display genome instability, an early marker for progression to malignancy. Our test is based on a recent report that genomic instability in vitro and in vivo is signaled by centrosome amplification (Fukasawa et al., 1996 ; Wang et al., 1997). In normal tissue cells, the centrosome, a discrete cytoplasmic domain that contains centrioles and forms the spindle poles in M, replicates once and only once in each cell cycle. Thus, a cell in G 1 contains a single centrosome, while cells in late S-, G 2 -and M-phase contain a pair of centrosomes. When cells become transformed, centrosomes depart from this duplication cycle and become amplified resulting in multiple (greater than two) centrosomes in each cell. Using an anti-centrosome antibody (Balczon et al, 1995 ) , we analyzed centrosome numbers in TEB and stroma cells as well as MNUJ-induced rat mammary gland tumors; and as shown in Figure 7 , centrosome number was found to be normal in TEBs and stromal cells but highly amplified in tumor cells. In order to make this procedure work on mammary gland cells in vivo, we adapted the centrosome antibody technique, formerly used only in tissue culture, to thick (5 gim) frozen sections of mammary glands and tumor tissue (He and Brinkley, 1997, manuscript in preparation). This procedure offers an promising new strategy for detecting early progression to malignancy in mammary glands and will be adapted for analyzing susceptible and refractory cells in mammary glands.
Task lb and c. Isolation and analysis of nuclear matrix proteins in normal mammary gland and mammary tumors by 2-D PAGE (continued from year 2).
One of our aims has been to analyze the nuclear matrix proteins components to terminal end buds (TEBs) and alveolar buds (ABs) in control rat mammary glands and in glands from animals treated with E and P hormones and MNU. As described in a previous progress report, we have succeeded in carrying out a comparative analysis of nuclear matrix proteins from the TEBs and ABs and adjacent stroma. Forty-five day old rats were injected with 0.5% Trypan Blue in the nipple revealing the mammary gland tree. Regions such as those shown in Figure 8 were separately collected under the dissecting microscope by digesting with collegenase (2 mg/ml) until ducts and TEBs free of stroma were free of surrounding stroma. The stroma cell fraction collected from either the TEB area or the AB area was separated by centrifugation as shown in a previous progress report. Our progress in obtaining gels from these samples has been delayed somewhat due to personnel changes in the Protein Analysis Core Laboratory at Baylor. When we failed to obtain satisfactory results with the new personnel, we were forced to contract with a private company (see Methods Section) to provide the 2-D silver-stained gels. Results shown in Figure 9 indicate that a specific nuclear matrix protein profile was found to be specifically localized in either TEB or AB, as reported in the previous progress report. A somewhat different profile was found in the stroma preparations. These gels indicate that specific marker proteins can be found in the four compartments sampled and that stroma associated with the TEB region may express proteins different from the stroma collected from the AB region. We have continued to analyze nuclear matrix proteins in these regions in additional samples. In addition, nuclear matrix proteins were analyzed in two separate samples of MNU-induced rat mammary tumors and compared to patterns found in both mammary epithelial and stromal cells. As shown in Figure 9 , at least two peptides were found to be specifically expressed in both tumors that were not found in the normal differentiated tissue samples. Some gel spots, possibly representing keratins (acidic peptides of approximately 55kD), indicate that both mammary tumors were derived from epithelial cells of the TEB.
CONCLUSIONS
Thus far, 14 clones isolated from the TEB DD-PCR fraction have been sequenced. Three clones of unknown identity are preferentially expressed in the TEB fraction. A cDNA library prepared from RNA isolated from 45 day old rats is currently being screened for full length clones. Full length cDNA clones to two known cDNAs encoding p190-B and adrenomedullin have been obtained and used for Northern blots to measure the levels of their respective mRNAs during mammary gland development. Antibodies to p190-B and adrenomedullin are being used to localize and study their function. An affinity purified antipeptide antibody to p190-B has been demonstrated to recognize authentic p190-B expressed in COS-1 cells. Both of these proteins appear to be expressed in the TEB and may play important roles in regulating TEB proliferation and apoptosis. Procedures have been developed to isolate nuclear matrix proteins from the TEB and preliminary 2D PAGE analysis has identified several unique proteins in this fraction. Procedures have also been optimized for measuring cell cycle kinetics and centrosome amplification in frozen sections using confocal microscropy. Finally, the steroid hormone regulation of Wnt-2 and Wnt-5B have been studied in intact mice and PRKO mice. Estrogen exerts an acute inhibition of stromal Wnt-2 expression in the absence of the progesterone receptor, Lysates from nontransfected (NT) and transfected (T) COS-1 cells were resolved on 6% SDS-PAGE and blotted onto PVDF membranes as described in Materials and Methods. Filters were cut into strips and either A) incubated with antibody to p190-B B). incubated with Ab to p190-B that was competed with its specific peptide prior to incubation or C). incubated with Ab to p190-B that was competed with a non-specific peptide. Nuclear matrix proteins specific mammary gland compartments. 2-D gels of nuclear matrix proteins isolated from different compartments of 45 day old rats include TEBs, ABs, stroma from TEB, and stroma from AB region. In addition, gels from two separate tumor samples display protein spots that corresponded to spots on gels representing the TEB sample indicating likely origin of these two tumors. Such gels will be useful in determining the tissue cells from which the tumor originated. ways plays an important role in initiating and supportmammary gland development was examined in ing mammary gland transformation. Both hormonal progesterone receptor knockout (PRKO) mice usand developmental status are known to be important ing reciprocal transplantation experiments to infactors in the etiology of breast cancer. These horvestigate the effects of the stromal and epithelial monal and developmental cues are often mediated at PRs on ductal and lobuloalveolar development, the molecular level by a combination of systemic horThe absence of PR in transplanted donor epithemones and locally acting growth factors. Synergism lium, but not in recipient stroma, prevented normal among locally acting growth factors enhances and lobuloalveolar development in response to estroaugments the diversity of potential signals transmitted gen (E) and progesterone (P) treatment. Conto the epithelial and stromal components of the gland. versely, the presence of PR in the transplanted This synergism can be stimulatory or inhibitory and donor epithelium, but not in the recipient stroma, can affect gene expression in the epithelium and revealed that PR in the stroma may be necessary mesenchyme. for ductal development. Members of the Wnt Estrogen (E) and progesterone (P), in cooperation growth factor family, Wnt-2 and Wnt-5B, were emwith pituitary hormones, are the primary systemic horployed as molecular markers of steroid hormone mones required for the induction of proliferation and action in the mammary gland stroma and epithedifferentiation of epithelial and stromal cells leading lium, respectively, to investigate the systemic efultimately to the formation of ductal and alveolar strucfects of E and P. Hormonal treatment of intact, tures during mammary gland development. The inovariectomized, and PR-1 -mice and mice after teraction of E and P with GH, PRL, and insulin in transplantation of PR-'-epithelium into wild type regulating this differentiative process has been well (PR-'+) stroma demonstrated that these two lodocumented (1). Steroid hormones also regulate the cally acting growth factors are regulated by indeexpression of a number of different locally acting pendent mechanisms. Wnt-2 is acutely repressed growth factors, including members of the epidermal by E alone, while Wnt-5B gene expression is ingrowth factor, insulin-like growth factor, and fibroblast duced only after chronic treatment with both E and growth factor (FGF) families (2, 3). Most of these P. Wnt 51 appears to be one of the few molecular growth factors exhibit localized effects due to protein P.rker Wnt 5 ap tion be one o y the l. stability, adhesion and residence in extracellular maThis study suggests that the regulation of maintrix, transport and secretion, and availability of receptor molecules. For this reason they are believed to act mary gland development by steroid hormones is as local mediators of the differentiative and proliferamediated byand disiceffeentsal grofthe fatoroma d tive signals of the systemic hormones. Systemic regepithelial PR and differential growth factor expresulation of locally acting growth factor activity allows for sion. (Molecular Endocrinology 11: 801-811, 1997) fine regulation of large-scale developmentally associated proliferative and differentiative functions. Mammary gland development is dependent on physical, molecular, and often reciprocal, interactions between the stromal and epithelial compartments (4). separate and recombine epithelial and stromal cornthelium (13) . This characteristic allows the analysis partments in vivo, makes the mammary gland an exof interactions between epithelium and stroma in cellent model system in which to study these interacvivo. The PR is present in both epithelial and stromal tions. Evidence for this reciprocal dependence has compartments of the murine mammary gland (5, 14) . been demonstrated in classic recombination experiTo establish the role of the PR in each of these ments between the epithelial and stromal androgen compartments, reciprocal transplantation experireceptor pathways (4). The specific role of the epithements were performed using epithelium and stroma lial and stromal PR in the development and differentiderived from syngeneic 129SvEv PR-'-and PR+'+ ation of the mammary gland is unclear (5, 6) . mice, respectively. PR-'-epithelium transplanted Wnt-1, the progenitor of a family of related growth into the cleared fat pads of PR+/+ mice penetrated factors, was discovered in mouse mammary tumors and filled the stroma with ductal structures (Fig. 1A) . as a result of proviral activation (7) . Members of the Interestingly, the PR-1-epithelium failed to develop Wnt gene family are expressed in invertebrates and alveoli and to display an increase in the number of vertebrates where they regulate cell fate and pattern secondary ductal branches in response to steroid formation (8) . Wnt genes, other than Wnt-1, are exhormone treatment (Fig. 1 B) . The control ipsilateral pressed in the mammary glands of mice in a develglands from the host animal responded as expected opmentally specific pattern (9-11). The function of to steroid hormone treatment with alveolar proliferthese endogenous Wnt genes during mammary ation (Fig. 1, D vs. C). This result demonstrates that gland development is unknown. From these studies the PR in the epithelium is required for normal lobuit is apparent that Wnt gene expression is tightly loalveolar formation and differentiation of the epiregulated and is dependent on the developmental thelium. In addition, the presence of PR-regulated state of the mammary gland. In BALB/c mice, Wnt-2 signaling pathway in the stroma cannot compensate is expressed primarily during early ductal developfor the lack of PR in the epithelium. In contrast, ment, 5-8 weeks postnatally, coincident with time of PR+/+ epithelium transplanted into the cleared fat PR induction by E, and is markedly down-regulated pad of PR-/-hosts and treated with E and P exhibat the onset of pregnancy. Conversely, Wnt-5B tranited lobuloalveolar development (Fig. 2D ). An inscripts are detectable in the late virgin gland at [6] [7] [8] [9] [10] [11] [12] crease in secondary branching in these E-and Pweeks of age but increase markedly during pregtreated transplants can be clearly seen under higher nancy, reaching a peak at day 18. Wnt-5B expresmagnification (Fig. 2F, arrow) . However, an unexsion is localized primarily in the ductal and Iobuloalpected, marked reduction in the extent of ductal veolar cells, while Wnt-2 expression is detected in outgrowth was observed in these transplants after the stroma (9, 11). These results suggest that E and P may play a role in regulating Wnt-2 and Wnt-5B gene expression in both the stroma and epithelium. This restricted pattern of gene expression is indic-A ative of molecules that may be involved in the developmental processes of the gland.
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In this study the progesterone receptor knockout (PRKO) mouse (12) has been used for reciprocal transplantation experiments in syngeneic mice to investigate the distinct roles of the stromal and epithelial PR in mammary ductal and alveolar development. Wnt-2 and -5B provided specific molecular markers of ste-
C D
roid hormone action in the mammary gland stroma ko and epithelium, respectively. The PRKO mouse permitted definition of the unique effects of P distinct from those mediated by E on Wnt gene expression. This experimental approach should facilitate the identifica-/ tion of other steroid-mediated local growth factors on mammary gland development. pression levels at the onset of pregnancy. Wnt-2 appears to be expressed primarily in the mammary gland stroma, and Wnt-2 transcripts have been detected in the cleared mammary fat pad (9, 11), whereas Wnt-5B is expressed specifically in ductal and lobuloalveolar cells (11). Thus, these locally acting growth factors provide excellent molecular markers to investigate the role of steroid receptors on ductal and lobuloalveolar development. First, however, it was necessary to establish whether E and P either alone or in combination could regulate
•4
i .-,, the expression of Wnt-2 and Wnt-5B in a manner analogous to that observed during mammary gland 4development.
BALB/c mice were treated with E and P to mimic the onset of pregnancy. RNA from the M mammary glands of hormonally treated and untreated, ovx, and intact mice were examined for changes in gene expression using a quantitative, RT-PCR method (9) . A decrease of approximately . A 2-fold decrease (P < 0.002) in Wnt-2 and PR-'-(C, D, E, and F) stroma. After 10 weeks of gene expression is observed after only 2 days of E growth, the mice were injected daily with E and P subcuand P treatment. Wnt-2 gene expression decreased taneously, and the mammary glands were collected at day progressively with daily E and P treatment and re-0 (A, C, and E) and day 8 (B, D, and F). Alveolar formation is evident in PR+/÷ (epithelium) PR-/-(stroma) after 8 days mained low to day 12 (data not shown). This deof E and P treatment (arrow in F). Note the reduction in crease in gene expression of Wnt-2 is not, however, ductal development in PR-/-/PR+/÷ (D) compared with as dramatic (20-fold) as that observed after the onboth PR÷/÷ (B) and PR-/-epithelium (Fig. 1, A and B) .
set of pregnancy (9) . PR+/+ epithelium in PR+/+ stroma responds to steroid Circulating E and P can cause cyclical repression hormone treatment with extensive alveolar growth and an and induction of PR expression levels and possibly increase in secondary branching (B). The arrows in A and attenuate the molecular effects of pharmacological B define the site of transplantation. Magnification in panels A, B, C, and D is defined by bar in A = 2 mm. Magnification doses of E and P. To eliminate the effects of endogin panels E and F is defined by bar in E = 0.75 mm.
enous ovarian hormones, three groups of ovx mice (PR-/-/PR÷/÷, n = 4 and PR÷/+/PR÷/÷, n = 4).
were implanted subcutaneously for 14 days with beeswax pellets that contained E and P together, E alone, or carrier. The thoracic mammary glands were col-10 weeks of growth (Fig. 2C) , as compared with the lected from three animals at each time point within PR+/' (Fig. 2, A and B) and the PR` (Fig. 1A) each treatment group at 1, 3, and 14 days after imepithelium transplanted into the PR+/' stroma. The plantation of the pellets. A 3-fold decrease relative to same PR+/+ epithelium transplanted in PR+/+ the day 1 E and P treatment group was observed in stroma responded as expected to steroid hormone Wnt-2 expression after 3 days, increasing to 5-fold at treatment with extensive alveolar growth and an 14 days compared with control (n = 3, P < 0.001, Fig.  increase in secondary branching (Fig. 2B) . The 2B). Interestingly, mice treated with E alone showed outgrowths from the PR'/+ epithelium transplanted the same 5-fold decrease relative to day 1 E alone into the PR-/-stroma also displayed unusual termice in Wnt-2 gene expression after 14 days (n = 3, minal endbuds (Fig. 2, C and E) . P < 0.001).
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4-fold by day 8 of E and P treatment of intact mice as compared with the untreated (time zero) mice and was 40- maximally induced by day 16 (P < 0.004, n = 3) as illustrated in Fig. 4A . Thus, the increase in Wnt-5B /, gene expression, which parallels that observed during S30.
midpregnancy, requires chronic E and P treatment.
U
The pattern of Wnt-5B expression in the ovx mice (Fig.  Z  44B) was similar to that observed in the intact animal o 20 but displayed a more dramatic response. Wnt-5B expression remained low at day 1 and day 3 but in-[ ]creased 9-fold at day 14 relative to the day 1 E-and Z 10-P-treated group (P < 0.001, n = 3). In contrast to the B. glands of BALB/c mice treated with E and P, E, and vehicle beeswax implants for 1, 3, and 14 days. E refers to treatment z with E alone for the number of days designated. The absolute 10-values for the entire control group (C) were low in this experiment, possibly due to an effect of the vehicle, but did not 0 change significantly with time. Values represent the mean + EP1 EP 3 EP 14 El E3 E14 C1 C 3 C14 SEM. The stars denote that EP 14 and E 14 are statistically DAYS OF HORMONAL TREATMENT different from EP 1 and E 1, respectively; P < 0.001, n = 3. Fig. 4 . The Response of Wnt-5B Gene Expression in Intact (A) and ovx (B) BALB/c Mice to E and P Treatment Wnt-5B Expression Is Induced by E and P in ovx A, Quantitative RT-PCR analysis of RNA from mammary and Intact Mice glands of BALB/c mice injected daily with E and P, subcutaneously, for 18 days. Values represent mean ± SEM. The star denotes that EP 16 is statistically different from EP 0, P < 0.004, n = 3. B, Quantitative RT-PCR analysis of RNA from expression is observed initially at 6-8 weeks in the mammary glands of BALB/c mice treated with E and P beesvirgin mouse and increases at the onset of pregnancy wax implants for 1,3, and 14 days. Values represent mean ± with maximal expression observed at day 16-18 of SEM. The star denotes that EP 14 is statistically different from pregnancy (9-11). Wnt-5B expression increased EP 1; P < 0.001, n 3.
may reflect the sensitization of the gland to P due to (1, 15) . Surprisingly, at day 8 some major ducts disthe absence of endogenous hormones and a rapid played a ductal hypertrophy (Fig. 5G, arrow) . This hyinduction of PR gene expression.
pertrophy has been observed in mammary glands of mice implanted with hepatocyte-growth factor (HGF) Morphological Changes in Normal and Steroid and treated with E and P (16). Unlike the alveolar Hormone-Treated Mice Correlate with the budding, this ductal hypertrophy was not transient and Changes in Wnt Gene Expression was still detectable in some glands at day 12-16 ( Fig.  5H) . Permanent alveoli appeared at day 12 and inChanges in Wnt-2 and Wnt-5B gene expression are creased in number and density throughout the remaincoincident with morphological changes observed in der of the treatment. This progression of morphologthe mammary gland in response to E and P treatment ical changes can be compared with the normal gland (Fig. 5) . Mammary glands of 12-day E-and P-treated (1). During pregnancy, alveoli and secondary branch-BALB/c mice (Fig. 5H ) exhibit a morphology similar to ing appear by day 4 and increase in density and numthat observed in an 8-day pregnant mouse. Several ber with the progression of pregnancy (Fig. 5 , C and differences were observed, however, between the ste-D). roid hormone-treated glands and those from the norThese morphological alterations observed in hormal midpregnant mouse, especially when comparing monally treated and normal mammary glands can be the first few days after hormone administration. For correlated with the E-and P-induced changes in example, on the second day of treatment, transient Wnt-2 and Wnt-5B gene expression. The appearance alveolar proliferation was observed (Fig. 5F ). However, of transient alveoli at day 2 coincides with the deby the fourth day these alveoli were no longer detectcrease in Wnt-2 expression observed in E-and Pable, and a decrease in the amount of secondary treated and normal glands. Conversely, permanent branches was observed (Fig. 5 ). This transient alveolar and functionally capable alveoli appear after 4-8 days budding has not been reported in mice treated with of E and P treatment, preceding the increase in pharmacological doses of E and P but is similar to the Wnt-5B expression. P concentrations increase gradueffect observed in some strains of mice who respond ally during pregnancy, affecting the formation of alveoli to ovarian cycling by producing a transient alveolar and the induction of the differentiated alveolar phenoproliferation in the mature virgin gland. This phenomtype (6, 17) . Appropriately, the increase in Wnt-5B ena has, however, not been observed in BALB/c mice expression in the E-and P-treated mouse requires termined in PR-'-mice (12) after treatment with E and Gene Expression in PR` Mammary Glands and P. Wnt-5B gene expression did not change in rein PR-1-Epithelium Transplanted into PR"'+ sponse to E and P treatment in PR-1-mice (n = 3, Fig. Stroma after E and P Treatment 6A). However, the E and P repression of Wnt-2 expression was still observed but was not significant The response of Wnt-2 and Wnt-5B gene expression until day 8 of hormone treatment (P < 0.003, n = 3, to the onset of pregnancy and exogenous E and P -5B gene expression from PR-1-mammary glands after daily injections with E and P, subcutaneously, for 0, 4, and 8 days (n = 3). B, Quantitative RT-PCR analysis of Wnt-2 gene expression from PR-'-mammary glands after daily injections with E and P, subcutaneously, for 0, 4, and 8 days. The star denotes that EP 8 is statistically different from EP 0; P < 0.001, n = 3. C and D, PR-'-epithelium was transplanted into cleared fat pads of PR+I+ 129SvEv mice. After 10 weeks of growth, the mice were treated with E and P. C, Quantitative RT-PCR analysis of Wnt-5B gene expression in transplanted mammary glands after daily injections with E and P, subcutaneously, for 0, 4, and 8 days. Values represent the mean -_ SEM (n = 6). D, Quantitative RT-PCR analysis of Wnt-2 gene expression in transplanted mammary glands after daily injections with E and P, subcutaneously., for 0, 4, and 8 days. Values represent the mean _' SEM. The star denotes that EP 8 is statistically different from EP 0; P < 0.013, n = 6. pression was observed in the absence of any detectthat the stroma fails to generate signals upon which able changes in mammary gland morphology in the the ductal growth of the epithelium is dependent. In PR-1 -mice. contrast, in the PR-'-mouse, the PR-'-epithelium, in To determine whether stromal or epithelial PRs were the presence of PR-'-stroma, has adapted to the involved in differential Wnt gene response, the levels absence of reciprocal signals, and the epithelium has of Wnt transcripts were quantitated in RNA isolated become independent of these inputs required for ducfrom the previously described transplants. The role of tal growth. This hormone-dependent reciprocity of the epithelium in the induction of Wnt-2 and Wnt-5B growth regulation has been observed previously in gene regulation was examined using PR-'-epitherecombination experiments with wild type and TfM lium, transplanted into the stromal fat pad of cleared androgen-insensitive mammary glands. These exper-PR+'+ hosts. In these transplants no increase in the iments revealed that the epithelium can induce the level of P-dependent Wnt-5B expression was obexpression of mesenchymal androgen receptors. In served after 8 days of E and P treatment (n = 6, Fig. turn, the mesenchyme condenses around the epithe-6C). To confirm that the low level of Wnt-5B expreslium and causes an epithelial regression (18, 19) . sion seen in the different samples was due to the The PR in the stroma is expressed in a temporally response in the epithelium and not due to absence or distinct pattern from the epithelial receptor, has a difdegradation of RNA, the expression of glyceraldeferent signaling mechanism, and affects a separate hyde-3-phosphate dehydrogenase (G3PDH) was also group of target genes (5) . Therefore, these data supanalyzed by RT-PCR. G3PDH transcripts are readily port the theory of two separate functional effects of detectable and constant throughout the treatment pemammary gland PR based on their compartmentalizariod (data not shown). The same 129SvEv mice contion and roles in development. The unexpected results taining transplanted PR-'-epithelium and treated observed in transplants of PR+'÷ epithelium in the with E and P for 8 days still possessed the ability to PR-'-stroma suggest that there is a P-dependent repress Wnt-2 expression when subjected to steroid stromal signal for ductal development. Recent in vivo hormone treatment (P < 0.013, n = 3, Fig. 6D ). Interstudies of murine mammary glands treated with HGF estingly, the reduction of Wnt-2 gene expression was in the presence of E and P suggest that HGF is a again delayed requiring 8 days of steroid hormone potential candidate second messenger for ductal treatment as observed previously in PRt -mice. growth in the mammary gland (16, 20) . HGF-treated mammary glands respond to E and P by stimulating ductal growth. Interestingly, this growth factor has DISCUSSION also been shown to regulate Wnt-5A expression (21) . If this hypothesis is valid, it may be possible to rescue PR Deficiency in the Stroma and Epithelium Has the PR-'-stroma defect by the direct addition of HGF. Distinct Effects on Mammary Gland Development Unfortunately, because HGF knockouts are embryonic lethal and die before E16.5, no information has been The absence of lobuloalveolar development in the obtained to date on mammary ductal development in PR-'-transplants into the PR+l+ fat pad after steroid these knockout mice (22) . hormone treatment indicates that the PR in the epithelium is required for this stage of mammary gland Wnt-2 and Wnt-5B Gene Expression Are development. These results are consistent with previRegulated Independently by Steroid Hormones ous studies showing that the absence of the PR influences lobuloalveolar development (12). Furthermore, This study demonstrates that two developmentally in the reciprocal transplants, PR+`+ epithelium into regulated Wnt genes are regulated by distinct mech-PR-'-stroma (Fig. 2, D and E) , lobuloalveolar develanisms. The unique temporal and spatial patterns of opment was observed in response to E and P, indiexpression of Wnt-2 and Wnt-5B suggest that these cating that the absence of the PR in the stroma does genes may play some role in the development of the not significantly impair the ability of the epithelium to mammary gland. The response of Wnt-2 and undergo alveolar differentiation. However, ductal Wnt-5B to E and P treatment indicates that these growth was impaired, as the PR+'+ epithelium failed to genes are useful markers for the action of E in the fill the PR-'-fat pad. In addition to the limited ductal virgin mammary gland, and for P during pregnancy, development, unusual distended endbuds were respectively. Wnt-2 gene expression is highest in present in these outgrowths. This restricted ductal the immature virgin gland of BALB/c mice and degrowth may be due to disruption of reciprocal interclines rapidly at the onset of pregnancy (9) . In ovx actions between the stromal and epithelial compartand intact BALB/c mice this effect can be mimicked ments required for this stage of development. Less with the addition of pharmacological doses of E. dramatic effects on ductal morphogenesis have been This acute repression of Wnt-2 gene expression is observed in the PR-/-mouse (12). This suggests that correlated with the appearance of lobuloalveolar the PR-/-stroma, when recombined with PR-/+ epstructures and the termination of ductal developithelium in vivo, lacks the mechanism to correctly inment. Conversely, an increase in Wnt-5B gene exteract with and stimulate growth in the epithelium and pression in ovx and intact mice requires chronic Effects on Development from the ovaries, the basal levels of Wnt-5B expression are probably significantly reduced, thereby alThe development of the mammary gland is dependent lowing an enhanced response. Wnt 5B provides one on the interaction and cooperation of growth factors of the few molecular endpoints for the action of P, and hormones functioning through the stromal and and changes in Wnt 5B are coincident with lobuloalepithelial compartments. Studies of PRL, epidermal veolar development, growth factor, FGF, TGFa and /3, insulin-like growth The results from the PR` studies demonstrate factor, and HGF action reveal that they are regulated in that Wnt-5B gene expression is induced by P and specific spatial and temporal patterns and have efdependent on the presence of PR specifically in the fects on proliferation and differentiation in mammary epithelial compartment. E alone has no effect on gland development (1, 27-30). The developmentally Wnt-5B expression. Interestingly, the PR present in associated expression pattern, their role in the develthe stroma cannot compensate for the absence of PR opment of other organisms, biochemical characterisin the epithelium for lobuloalveolar development or for tics, and hormonal regulation of the Wnts suggest that induction of Wnt 5B gene expression. This result imthey are members of this complex family of locally plies that P acts directly on the epithelium to induce acting growth factors. lobuloalveolar development and, either directly or inThe function of the Wnt genes in the development of directly, to activate Wnt-5B gene expression. E is rethe mammary gland can only be inferred from limited quired for induction and maintenance of PR expresexpression studies in vivo and in vitro and functional sion in the mammary gland (6) . Therefore, it is unlikely studies in other organisms. Wingless, the Drosophila that the regulation of Wnt-5B expression is indepenhomolog of Wnt-1, has proliferative, inductive, and cell dent of E.
fate determination functions (8) . In addition, Wnt genes Wnt-2 gene expression was inhibited by adminishave demonstrated functional roles in Xenopus, tration of E in both PR-/-mice and in transplanted mouse, and chicken (31) (32) (33) (34) (35) (36) . These diverse studies PR-'-epithelium. These results suggest that Wnt-2 revealed that Wnt genes can possess inductive, gene expression is not primarily regulated by PR growth-stimulatory, and growth-restrictive functions geneexpessin i notpriaril reulatd b PR all within a single organism. signaling. In the PR-/-studies there was a delay in In the a gland r i f the kinetics of the Wnt-2 response. The absence of influences the proliferation of mammary epithelium the PR may have restricted the development of the (37). The expression of Wnt-4 and Wnt-5A has been gland in these mice and slowed the appearance of inversely correlated with proliferation in mammary epthe ER, which normally appears at 4 weeks of age ithelial cells (38). Because of its localization both within (23, 24) . Alternatively, the absence of the PR could an aroun th e highly p olifer ativ n budh it inflenc reiprcalinteactonsbeteenthe and around the highly proliferative terminal endbud, it influence reciprocal interactions between the is possible that Wnt-2 has a role in regulating proliferstroma and the epithelium, thereby preventing ation in the virgin gland. The pattern of Wnt-5B exproper induction of ERs. ER gene expression is afpression and its dependence on the PR suggests that fected by feedback controls between E and other it interacts with cells in a more differentiated state. hormones including P (14) .
Interestingly, proliferation is high in the pregnant gland Previous studies performed in Parks mice demoncoincident with the increase in Wnt-5B expression. strated Wnt-2 expression through midpregnancy and Localization of Wnt-5B transcripts to the ductal epia repression of Wnt-2 and Wnt-5B expression after thelium reveals it is expressed in the proper cellular ovariectomy (11). Parks mice possess virgin lobuloallocation to be involved in regulating proliferation in veolar development, which is absent in BALB/c mice, these cells. The localization of Wnt-5B and Wnt-2 tranand it is possible that this epithelial sensitivity to scripts to the ductal epithelial and stromal compartestrous-associated hormones alters the regulation of ments of the mammary gland (9, 11), respectively, Wnt-2 and Wnt-5B gene expression.
suggest that although these two genes may have sepThe rapid repression of Wnt-2 expression sugarate or even overlapping functional roles, their temgests the ER may be directly regulating Wnt-2. The poral and spatial expression patterns restrict their ac-ER is expressed in both the stroma and epithelium tivity to specific stages of development. Therefore, it is including the endbud (5, 14, (23) (24) (25) . Interestingly, probable that the expression of these Wnt genes is PR is induced by the ER-signaling pathway in the regulated in a specific manner to restrict their funcepithelial compartment 48 h after initial addition of E tional activities to particular developmental stages in (26) . This temporal delay in receptor response cointhe mammary gland. cides exactly with the initial decrease observed in Wnt-2 gene expression after hormonal treatment.
Alteration of Wnt Gene Expression Can Therefore, the timing of this E-induced gene expresTransform Mammary Epithelium sion and localization of some Wnt-2 transcripts in the epithelium suggests that Wnt-2 could be reguIn the mammary gland, ectopic expression of the Wnt lated directly by E.
genes has dramatic consequences on the transforma- (41, 42) .
and stained with hematoxylin as described previously (52). For isolation of RNA, mammary glands were homogenized in These in vitro transfection experiments have revealed a PT2000 Polytron (Brinkmann, Westbury, NY) with RNazol that separate classes of Wnts exist that are distin-(Biotecx, Houston, TX) as described by the manufacturer or guished by their transforming ability (43) , although the homogenized in 4 M guanididium isothiocynate (Sigma, St. properties defined in these in vitro assays do not alLouis MO) and isolated by CsCI centrifugation method. RNA was quantitated spectrophotometrically and stored at -20 C ways correspond to their effects in vivo (R. C. Humin 70% ethanol. phreys and J. M. Rosen, submitted for publication).
In addition, overexpression of Wnt genes, including Construction and Transcription of cRNA Templates Wnt-2 and Wnt-5B, has been found associated with tumors in the breast and intestinal epithelium (44-47).
Quantitative noncompetitive RT-PCR was performed as preThus, loss of regulatory control on these two Wnt viously described (9) . Complementary DNAs from Wnt-5B genes, as with other growth factor molecules like and Wnt-2 were prepared according to standard bacterial TGF-13 and EGE (48, 49) , has deleterious conseplasmid isolation protocols, and the DNA was purified on Qiagen (Qiagen, Chatsworth, CA) columns according to the quences for the development of the mammary gland.
manufacturer and isolated from the vector using unique reInterestingly, compartment switching of Wnt-2 exstriction enzymes. To construct the Wnt-2 cDNA deletion pression from breast fibroblasts to tumor epithelium template, Styl (New England Biolabs, Beverly, MA) was used has been observed recently in human breast tumors to excise a fragment from bases 493-580. Digestion products were separated from the small internal fragment, religated, (50) . Therefore, there is evidence for a critical role of and subcloned into the vector pBKSII (Stratagene, La Jolla, Wnt-2, and possibly Wnt-5B, in the transformation of CA). Clones were analyzed for a size difference and sethe gland. Since most of the Wnt knockouts are emquenced to confirm the location of the deletion. The Wnt-5B bryonic lethals resulting in neural or kidney defects, template was constructed in the same manner with an Aval the precise functional roles of these and other Wnt (New England Biolabs, Beverly MA) deletion of bases 501-576. Both templates were sequenced to confirm the orientafamily members on normal mammary gland develoption in the vector and the presence of an internal deletion. ment will require the use of tissue-specific or regulated These constructs were used as templates for in vitro tranknockouts.
scription reactions as described in Promega Protocols and To summarize, the Wnt genes act in a cell-autonoApplications Guide, ed 2 (Promega, Madison WI). The cRNA reactions were treated with 1 U of ribonuclease-free RQ1 mous manner in cooperation with other growth factors deoxyribonuclease in deoxyribonuclease buffer (Promega) and have pleuripotent effects on various developmenfor 60 min at 37 C and then extracted with phenol-chloroform tal processes within the same organism (8) . Wnt gene twice and precipitated with 3 M NaAc and 100% ethanol at expression can be differentially regulated by steroid -20 C. The cRNA was resuspended in Tris-EDTA, quantihormones in the mammary stroma and epithelium tated spectrophotometrically, and stored at -20 C in 70% ethanol. Each template was assayed by PCR to confirm the where they may act as locally acting growth factors to absence of contaminating cDNA template. Optimum RT-PCR influence ductal and lobuloalveolar development, conditions for each of the templates were developed that Hopefully, with the recent discovery of the Wnt recepallowed a linear response with respect to the RNA input and tor in Drosophila (51), the mechanism of Wnt action exhibited noncompetitive PCR. (-10,000 molecules) was added to each RT reaction as an of Medicine, courtesy of Dr. Daniel Medina. Mice carrying the internal standard to control for differences in RT and PCR PRKO mutation in the 129SvEv inbred genetic background reaction efficiency. were used in these studies. All animals were maintained
The primer sequences for the Wnt-2 and Wnt-5B amplifiaccording to IACUC approved guidelines.
cations, respectively, were: forward: 5'-AGTCGGGAATCGGCCTIGTTIACG-3' and reverse: 5'-AAAGTICTICGCGAAATGTCGGAAG-3';
forIsolation of Mammary Glands and RNA ward: 5'-GACAGCGCCGCGGCCATGCGC-3' and reverse: 5'-CAITFGCAGGCGACATCAGC-3'. PCR conditions were Number 4 (thoracic) mammary glands were removed from 94 C for 1 min, 60 C for 2 min, and 72 C for 3 min, for 30 aged matched 6-and 8-week-old virgin BALB/c and C3H
cycles and 94 C for 1 min, 65 C for 2 min, and 72 C for 3 min
